85 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 2 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x RNA TS TPMi x
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedkidney:16.9
liver:23.4
ABCG5ATP binding cassette subfamily G member 5Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
NucleusLiver cancer: 2.60e-5
Group enrichedduodenum:56.5
liver:28.4
small intestine:56.2
ABCG8ATP binding cassette subfamily G member 8Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesGroup enrichedduodenum:50.0
liver:34.0
small intestine:55.5
ADH4Alcohol dehydrogenase 4 (class II), pi polypeptideEnzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol
Liver cancer: 7.08e-6
Tissue enrichedliver:2628.5
AFPAlpha fetoproteinCancer-related genes
Disease related genes
Plasma proteins
Predicted secreted proteins
CytosolTissue enhancedliver:1.9
AHSGAlpha 2-HS glycoproteinCancer-related genes
Plasma proteins
Predicted secreted proteins
Golgi apparatusTissue enrichedliver:2823.4
AKR1D1Aldo-keto reductase family 1 member D1Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol
Liver cancer: 9.91e-5
Tissue enrichedliver:229.4
ALBAlbuminCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulum
Golgi apparatus
Stomach cancer: 7.87e-4
Tissue enrichedliver:105947.0
AMBPAlpha-1-microglobulin/bikunin precursorPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endometrial cancer: 1.20e-4
Tissue enrichedliver:5176.2
ANGAngiogeninCancer-related genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Liver cancer: 7.83e-5
Endometrial cancer: 6.85e-4
Tissue enrichedliver:1565.4
APOA1Apolipoprotein A1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Vesicles
Cytosol
Renal cancer: 1.67e-8
Liver cancer: 5.05e-4
Tissue enhancedliver:8458.6
small intestine:4128.6
APOA2Apolipoprotein A2Cancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enrichedliver:18325.0
APOA5Apolipoprotein A5Disease related genes
Plasma proteins
Predicted secreted proteins
Tissue enrichedliver:259.2
APOBApolipoprotein BCandidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Vesicles
Cytosol
Group enrichedduodenum:182.8
liver:618.9
small intestine:333.2
APOFApolipoprotein FPlasma proteins
Predicted secreted proteins
Tissue enrichedliver:220.1
APOHApolipoprotein HCandidate cardiovascular disease genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusLiver cancer: 2.39e-7
Renal cancer: 1.10e-6
Tissue enrichedliver:9090.4
ASGR1Asialoglycoprotein receptor 1Predicted intracellular proteins
Vesicles
Cell Junctions
Tissue enrichedliver:236.1
ASGR2Asialoglycoprotein receptor 2Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Endoplasmic reticulum
Plasma membrane
Tissue enrichedliver:317.7
BPIFB2BPI fold containing family B member 2Plasma proteins
Predicted secreted proteins
Transporters
VesiclesEndometrial cancer: 1.97e-5
Group enrichedesophagus:98.5
salivary gland:90.5
C2orf82Chromosome 2 open reading frame 82Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Nucleoli
Endometrial cancer: 3.56e-4
Tissue enhancedbreast:5.1
testis:4.1
C4BPAComplement component 4 binding protein alphaPlasma proteins
Predicted secreted proteins
Endometrial cancer: 6.37e-5
Liver cancer: 2.24e-4
Group enrichedliver:997.5
lung:262.3
CCL15C-C motif chemokine ligand 15Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Urothelial cancer: 3.02e-4
Tissue enhancedduodenum:21.5
rectum:30.6
small intestine:26.6
CCL16C-C motif chemokine ligand 16Cancer-related genes
Plasma proteins
Predicted secreted proteins
Tissue enrichedliver:60.8
CCR6C-C motif chemokine receptor 6CD markers
G-protein coupled receptors
Predicted membrane proteins
Tissue enhancedlymph node:20.4
tonsil:32.4
CDHR2Cadherin related family member 2Plasma proteins
Predicted membrane proteins
Renal cancer: 9.29e-4
Group enrichedduodenum:276.5
small intestine:260.3
CH507-152C13.3Predicted intracellular proteins
Nucleoplasm
Cytosol
Tissue enrichedkidney:57.2
CPB2Carboxypeptidase B2Enzymes
Plasma proteins
Predicted secreted proteins
Liver cancer: 2.06e-4
Tissue enrichedliver:755.5
CPN2Carboxypeptidase N subunit 2Plasma proteins
Predicted secreted proteins
Liver cancer: 2.05e-4
Renal cancer: 4.59e-4
Tissue enrichedliver:113.6
CPSF4LCleavage and polyadenylation specific factor 4 likePredicted intracellular proteins
Not detected
CRYAACrystallin alpha ADisease related genes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol
Tissue enrichedkidney:12.3
DGKKDiacylglycerol kinase kappaEnzymes
Predicted intracellular proteins
Tissue enrichedadrenal gland:4.5
DKK4Dickkopf WNT signaling pathway inhibitor 4Predicted secreted proteins
Tissue enhancedduodenum:2.4
esophagus:5.4
testis:2.7
DUSP9Dual specificity phosphatase 9Enzymes
Predicted intracellular proteins
Endoplasmic reticulumEndometrial cancer: 1.60e-4
Group enrichedkidney:29.0
placenta:103.3
F11Coagulation factor XICandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesLiver cancer: 3.29e-5
Tissue enhancedliver:180.1
F2Coagulation factor II, thrombinCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 6.75e-12
Tissue enrichedliver:627.3
F5Coagulation factor VCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatusStomach cancer: 3.39e-4
Group enrichedgallbladder:28.4
liver:93.7
placenta:68.2
FGAFibrinogen alpha chainCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Renal cancer: 4.23e-6
Liver cancer: 7.33e-4
Tissue enrichedliver:9265.4
FGBFibrinogen beta chainCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulumRenal cancer: 5.72e-5
Tissue enrichedliver:10006.0
FGGFibrinogen gamma chainCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 1.00e-6
Tissue enrichedliver:8699.0
FTCDFormimidoyltransferase cyclodeaminaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Plasma membrane
Cytosol
Pancreatic cancer: 6.78e-5
Liver cancer: 1.70e-4
Renal cancer: 5.78e-4
Group enrichedkidney:100.2
liver:184.7
GPHA2Glycoprotein hormone alpha 2Predicted secreted proteins
Group enrichedgallbladder:26.3
pancreas:76.9
GSTA1Glutathione S-transferase alpha 1Enzymes
Plasma proteins
Predicted intracellular proteins
CytosolRenal cancer: 3.71e-4
Lung cancer: 8.66e-4
Tissue enhancedadrenal gland:1136.4
kidney:1310.9
liver:1757.6
HAMPHepcidin antimicrobial peptideDisease related genes
Potential drug targets
Predicted secreted proteins
Transporters
Tissue enrichedliver:259.1
HEPACAMHepatic and glial cell adhesion moleculeDisease related genes
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesTissue enrichedcerebral cortex:80.7
HEPN1Hepatocellular carcinoma, down-regulated 1Predicted intracellular proteins
Golgi apparatusTissue enrichedcerebral cortex:79.5
HGFACHGF activatorCancer-related genes
Enzymes
Plasma proteins
Predicted secreted proteins
Renal cancer: 9.31e-4
Tissue enrichedliver:28.6
HPD4-hydroxyphenylpyruvate dioxygenaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nuclear specklesGroup enrichedkidney:529.9
liver:1293.2
HPRHaptoglobin-related proteinEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enrichedliver:444.1
HPXHemopexinCandidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Liver cancer: 2.26e-4
Tissue enrichedliver:2617.9
ITIH2Inter-alpha-trypsin inhibitor heavy chain 2Plasma proteins
Predicted secreted proteins
Golgi apparatusLiver cancer: 1.48e-4
Tissue enrichedliver:1093.4
Page of 2 | next »